Health & Medicine
"Holy Grail" of Anticoagulant Drugs Raises $11 Million in Funding
With the potential to save millions of lives, University of Cambridge's spin-off company XO1 Ltd. raised $11 million in funding to develop what some are calling the holy grail of anticoagulant drugs.
Latest Research Articles
Obese Fathers have Babies with High Body-fat
Sibling Rivalry Could have Serious Effects on Mental Health
Osteoporosis Drug Effective Against Treatment-Resistant Breast Cancer
Restless Leg Syndrome Linked to Shorter Life Expectancy in Men
Researchers Find Two Distinct Forms of Gulf War Illness
Too Much Sugar Increases Risk of Heart Failure
91-Year-Old Sets Bench Press World Record [VIDEO]
Second Woman Dies After Receiving Butt Implant From Miami Clinic
Fluorescent Protein Identified in Eel Could Revolutionize Testing for Liver Function
Eyeball Licking Linked with Rise of Pink Eye among Children in Japan
Sensor that Detects Melanoma via Odor Developed
Home Births Found Safer than Hospital Births for Some Low-Risk Women: Study
MOST POPULAR
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
Chinese Astronauts Create Oxygen and Rocket Fuel Using Artificial Photosynthesis in Space
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
